Literature DB >> 17286318

Reasons for antidepressant prescriptions in Canada.

Scott B Patten1, Eleonora Esposito, Brian Carter.   

Abstract

PURPOSE: To describe reasons reported by physicians making recommendations for treatment with antidepressant medications.
METHODS: Data collected by IMS Health Canada in a database called the Canadian Disease and Therapeutic Index (CDTI) were used in this analysis. CDTI data are collected from a representative sample of office-based physicians who complete diaries in their practices during selected sampling periods. A drug recommendation is recorded each time a treatment is recommended. The data are weighted to produce national estimates of the frequency of such recommendations.
RESULTS: The frequency of recommendations for antidepressant treatment increased between 2000 and 2004. However, there was a slight decrease in 2005. Two types of antidepressant medications, tricyclic antidepressants (TCAs) and trazodone showed distinct patterns of use. TCAs were more commonly used for non-psychiatric indications than for psychiatric indications, especially for sleep- and pain-related reasons. Trazodone was frequently recommended for sleep problems. The proportion of recommendations for depressive disorders for antidepressants as a group remained stable over the 5-year study period.
CONCLUSIONS: About one-third of antidepressant recommendations are for reasons other than depression. It can no longer be assumed that the frequency of antidepressant use is a measure of the frequency of pharmacological depression treatment. However, prescription data may be useful for tracking trends.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17286318     DOI: 10.1002/pds.1385

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  20 in total

1.  A Canadian Primary Care Sentinel Surveillance Network Study Evaluating Antidepressant Prescribing in Canada From 2006 to 2012.

Authors:  Rachael Morkem; David Barber; Tyler Williamson; Scott B Patten
Journal:  Can J Psychiatry       Date:  2015-12       Impact factor: 4.356

2.  The association between use of cardiovascular drugs and antidepressants: a nationwide register-based study.

Authors:  Kristina Johnell; Johan Fastbom
Journal:  Eur J Clin Pharmacol       Date:  2008-08-07       Impact factor: 2.953

3.  Dispensed prescriptions for quetiapine and other second-generation antipsychotics in Canada from 2005 to 2012: a descriptive study.

Authors:  Tamara Pringsheim; David M Gardner
Journal:  CMAJ Open       Date:  2014-10-01

4.  Antidepressant continuation in pregnancy and risk of gestational diabetes.

Authors:  Paige D Wartko; Noel S Weiss; Daniel A Enquobahrie; K C Gary Chan; Alyssa Stephenson-Famy; Beth A Mueller; Sascha Dublin
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-07-12       Impact factor: 2.890

Review 5.  A meta-analysis of the effects of antidepressants on cognitive functioning in depressed and non-depressed samples.

Authors:  Catherine E Prado; Stephanie Watt; Simon F Crowe
Journal:  Neuropsychol Rev       Date:  2018-02-14       Impact factor: 7.444

6.  Predictors of prescribed medication use for depression, anxiety, stress, and sleep problems in mid-aged Australian women.

Authors:  Margot J Schofield; Asaduzzaman Khan
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-06-07       Impact factor: 4.328

7.  Factors associated with changes in antidepressant use in a community-dwelling elderly cohort: the Three-City Study.

Authors:  Agnès Soudry; Carole Dufouil; Karen Ritchie; Jean-François Dartigues; Christophe Tzourio; Annick Alpérovitch
Journal:  Eur J Clin Pharmacol       Date:  2007-10-19       Impact factor: 2.953

8.  MATERNAL EXPERIENCE OF ABUSE IN CHILDHOOD AND DEPRESSIVE SYMPTOMS IN ADOLESCENT AND ADULT OFFSPRING: A 21-YEAR LONGITUDINAL STUDY.

Authors:  Andrea L Roberts; Ying Chen; Natalie Slopen; Katie A McLaughlin; Karestan C Koenen; Sydney Bryn Austin
Journal:  Depress Anxiety       Date:  2015-07-28       Impact factor: 6.505

9.  Antidepressant use and risk for preeclampsia.

Authors:  Kristin Palmsten; Krista F Huybrechts; Karin B Michels; Paige L Williams; Helen Mogun; Soko Setoguchi; Sonia Hernández-Díaz
Journal:  Epidemiology       Date:  2013-09       Impact factor: 4.822

10.  The Impact of Non-dopaminergic Medication on Quality of Life in Parkinson's Disease.

Authors:  Nicol G M Oonk; Kris L L Movig; Job van der Palen; Henk-Willem Nijmeijer; Mirjam E van Kesteren; Lucille D A Dorresteijn
Journal:  Clin Drug Investig       Date:  2021-08-10       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.